Drug Shortage Report for ACETYLCYSTEINE SOLUTION USP

Last updated on 2023-01-24 History
Report ID 171228
Drug Identification Number 02459906
Brand name ACETYLCYSTEINE SOLUTION USP
Common or Proper name ACETYLCYSTEINE SOLUTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ACETYLCYSTEINE
Strength(s) 200MG
Dosage form(s) SOLUTION
Route of administration ORAL INTRAVENOUS INHALATION ORAL INTRAVENOUS INHALATION
Packaging size 30ML
ATC code R05CB
ATC description EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-06
Estimated end date 2023-01-20
Actual end date 2023-01-20
Shortage status Resolved
Updated date 2023-01-24
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2023-01-24 French Compare
v14 2023-01-24 English Compare
v13 2023-01-16 French Compare
v12 2023-01-16 English Compare
v11 2023-01-09 French Compare
v10 2023-01-09 English Compare
v9 2022-12-30 French Compare
v8 2022-12-30 English Compare
v7 2022-11-18 English Compare
v6 2022-11-03 French Compare
v5 2022-11-03 English Compare
v4 2022-10-07 English Compare
v3 2022-10-06 French Compare
v2 2022-10-06 English Compare
v1 2022-10-06 English Compare

Showing 1 to 15 of 15